e-learning
resources
Virtual 2021
07.09.2021
Advances in asthma treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effects of nebulised beta-2 agonists on clinical observations in asthma exacerbations: a systematic review
C. Mortimer (Crawley, United Kingdom), D. Nikoletou (London, United Kingdom), A. Ooms (London, United Kingdom), J. Williams (Crawley, United Kingdom)
Source:
Virtual Congress 2021 – Advances in asthma treatment
Session:
Advances in asthma treatment
Session type:
E-poster
Number:
3533
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Mortimer (Crawley, United Kingdom), D. Nikoletou (London, United Kingdom), A. Ooms (London, United Kingdom), J. Williams (Crawley, United Kingdom). The effects of nebulised beta-2 agonists on clinical observations in asthma exacerbations: a systematic review. 3533
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Omalizumab reduces asthma exacerbations and oral corticosteroid use in patients with severe allergic asthma: a systematic review of observational studies
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019
Tiotropium provides greater improvements in FEV1 than leukotriene receptor antagonists as add-on to ICS in adults with asthma: a systematic review
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018
Does the use of inhaled corticosteroids in asthma benefit lung function in the long-term? A systematic review and meta-analysis
Source: Eur Respir Rev, 30 (159) 200185; 10.1183/16000617.0185-2020
Year: 2021
Inhaled corticosteroids in asthma and longitudinal change in lung function: a systematic review and meta-analysis
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
Factors influencing the relative effect of leukotriene receptor antagonists (LTRA) and inhaled corticosteroids (ICS) as monotherapy in persistent asthma: A systematic review
Source: Annual Congress 2011 - Asthma management and response
Year: 2011
Comparison of the efficacy and safety of long-acting anticholinergic and a combination of inhaled steroids and long-acting beta-2 agonist in moderate chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Deprescribing montelukast in children with asthma: a systematic review
Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches
Year: 2021
Medication use in COPD: systematic review and meta-analysis
Source: Annual Congress 2007 - Treatment and care of COPD
Year: 2007
Leukotriene receptor antagonists for allergic rhino-sinusitis: a systematic review and meta-analysis
Source: Eur Respir J 2003; 22: Suppl. 45, 109s
Year: 2003
The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019
The effect of additional use of short-acting beta2 agonist on exercise tolerance in patients with COPD on regular long-acting bronchodilators treatments
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
Systematic review: Does antibiotic treatment duration affect the outcomes of asthma and COPD exacerbations?
Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics
Year: 2017
ICS-formoterol reliever
versus
ICS and short-acting ß
2
-agonist reliever in asthma: a systematic review and meta-analysis
Source: ERJ Open Res, 7 (1) 00701-2020; 10.1183/23120541.00701-2020
Year: 2021
Evaluating inhaled corticosteroid use among pregnant women with asthma: systematic review and meta-analysis
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
Intravenous theophylline levels in children with acute asthma: A systematic review
Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies
Year: 2016
A systematic review of the use of physiological tests assessing the acute response to treatment during exacerbations of COPD
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020
Step-up of asthma therapy: an observational study comparing increased inhaled corticosteroid dosage to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007
Clinical review of long-term pranlukast therapy in adult patients with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 310s
Year: 2004
Effects of a single inhaled budesonide/formoterol dose on glucocorticoid receptor activity in sputum of COPD patients
Source: International Congress 2016 – Novel insights into the treatment of COPD
Year: 2016
Short-acting bronchodilator reversibility does not predict the response to long-term treatment by indacaterol 150 µg in COPD: REVERBREZ study
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept